Never before in history have we been so soberly aware of the importance of at-home blood sugar-monitoring device as many diabetic patients being holed up at home for days or even months in the teeth of the deadly COVID-19 pandemic.
Right at this moment, Chinese digital healthcare company Dnurse attended this year’s Consumer Electronics Show (CES) online, with new glucometers promising easier, more accessible and accurate care at home.
Dnurse came to the world’s largest consumer technology exposition with one simple goal — to help patients track their blood sugar readings at all times and ward off complications by real-time analysis in the comforts of their homes. With this goal, it has ushered its latest glucometer into the digital health space of the exposition. Digital health has long been defined by the annual exposition as a frontier that discovers new wellness technologies, improves health care, saves lives, and lowers costs. That’s exactly what Dnurse chimes in with — creating a tiny, affordable digital doctor in a diabetic patient’s pocket. Furthermore, by cementing customers’ reliance on its products and technologies, Dnurse also sets its sights on bulking up customer retention for multinational pharmaceutical companies, commercial insurers, pharmaceutical e-commerce platforms, and overseas retailers.
Of course, the CES 2021 was no stranger to smart glucometers, but Dnurse looks beyond the obvious and the familiar. For years, it has been pushing for a new mode that aligns monitoring app and smartphone-compatible glucometers with an around-the-clock health care. Dnurse’s smart gadgets are not in any way like the conventional ones with which only simple blood sugar readouts pop up. Instead, they act as digital doctors to make patients feel empowered to self-manage their disease through real-time sharing of readings with caregivers. To some extent, few startups or companies revolutionize at-home diabetic care as Dnurse does.
Here comes Dnurse’s signature product — Dnurse SPUG, a welcome addition to the digital health sector of this year’s CES. Dnurse SPUG is a pocket-sized blood glucose & uric acid monitor that can be plugged into your phone via a Type-C port. Small and simple as it is, the gadget can automatically transmit your blood sugar or uric acid data into the accompanying app in your phone, which analyzes your results and makes it easier for you to track diabetes-specific metrics, such as physical activity and medication adherence. For most patients at home, such product will come in handy and help them keep their blood sugar levels at bay, especially when nabbing an appointment with doctors is off the table.
Aside from tracking and transmitting readouts, Dnurse SPUG also comprehensively integrates the glucose & uric acid meter itself with chronic care management software and IDSS system, an intelligent decision-making support system. It’s what has made Dnurse SPUG special. Through such a mode blending data and intelligence into harmony, Dnurse can monitor progress remotely and keep an eye out for infections and other long-term complications.
Dnurse launched insulinK️® in 2017 CES which is an automatic insulin dosage tracker to collect user insulin injection behavior data and sync with Dnurse APP and sharing with caregivers. Till now, insulinK️® already assisted more than 30000 insulin patients managing their insulin compliance by cooperating with Novo Nordisk and Sanofi in 360 hospitals in China, and Dnurse is also planning new insulinK® to adapting with most of public insulin pen but not only Novo pen and Sanofi Solostar insulin pen.
Since its founding, Dnurse has held itself to a standard that diabetic patients’ needs should be met first while tailored care service should be delivered timely. With its products being sought after in more than 15 countries and regions across the globe, Dnurse now wants to muscle into a health care sector with much potential to be exploited in more corners of the world. As Market Research Engine put it, the digital health monitoring market is projected to grow to $245.5 billion by 2024, and that will be driven by a lot of new advances in health monitoring devices that are wearable.
Still, a growing presence worldwide springs from forward-looking technologies, while an excellent reputation springs from responsibility and cooperation. To earn the cachet of being safe, smart, private and easy-to-handle, Dnurse will continue to team up with more partners to generate more products that create more sophisticated, empathetic interactions with technology.
To Dnurse, participating in the CES 2021 is just one important step toward helping more diabetic patients from China and even beyond build a greater picture of their health.
Feel comfortable to contact for any further questions: